Esperion Therapeutics, Inc. (ESPR) Forms $73.14 Double Top; Koppers Holdings (KOP) Has 1.06 Sentiment

Esperion Therapeutics, Inc. (ESPR) formed double top with $79.72 target or 9.00% above today’s $73.14 share price. Esperion Therapeutics, Inc. (ESPR) has $1.94B valuation. The stock decreased 4.13% or $3.15 during the last trading session, reaching $73.14. About 810,259 shares traded or 31.34% up from the average. Esperion Therapeutics, Inc. (NASDAQ:ESPR) has risen 133.75% since March 9, 2017 and is uptrending. It has outperformed by 117.05% the S&P500.

Koppers Holdings Inc. provides treated wood products, wood treatment chemicals, and carbon compounds in the United States and internationally. The company has market cap of $878.93 million. The firm operates through three divisions: Railroad and Utility Products and Services , Performance Chemicals (PC), and Carbon Materials and Chemicals (CMC). It has a 18.36 P/E ratio. The RUPS segment procures and treats crossties, switch ties, and various types of lumber used for railroad bridges and crossings.

Among 18 analysts covering Esperion Therapeutics (NASDAQ:ESPR), 10 have Buy rating, 0 Sell and 8 Hold. Therefore 56% are positive. Esperion Therapeutics had 58 analyst reports since July 28, 2015 according to SRatingsIntel. Needham maintained it with “Strong Buy” rating and $58 target in Monday, March 20 report. On Monday, March 20 the stock rating was upgraded by Credit Suisse to “Neutral”. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) has “Strong Buy” rating given on Wednesday, August 19 by Needham. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) earned “Overweight” rating by Barclays Capital on Wednesday, February 24. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) has “Neutral” rating given on Monday, November 14 by Citigroup. Credit Suisse downgraded Esperion Therapeutics, Inc. (NASDAQ:ESPR) on Wednesday, June 29 to “Underperform” rating. JP Morgan downgraded Esperion Therapeutics, Inc. (NASDAQ:ESPR) rating on Wednesday, June 29. JP Morgan has “Neutral” rating and $15 target. On Wednesday, October 18 the stock rating was maintained by Cowen & Co with “Buy”. The rating was maintained by JP Morgan with “Neutral” on Wednesday, February 21. UBS maintained it with “Buy” rating and $88.0 target in Wednesday, January 17 report.

Investors sentiment decreased to 1.33 in Q3 2017. Its down 0.34, from 1.67 in 2017Q2. It is negative, as 11 investors sold Esperion Therapeutics, Inc. shares while 34 reduced holdings. 30 funds opened positions while 45 raised stakes. 22.73 million shares or 17.55% more from 19.33 million shares in 2017Q2 were reported. Nationwide Fund holds 22,952 shares. Equitec Proprietary Markets Ltd Llc holds 0% or 400 shares. Us National Bank & Trust De invested in 11,051 shares or 0% of the stock. Perceptive Advisors Ltd Limited Liability Company holds 0.02% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 10,769 shares. Tudor Invest Et Al reported 42,954 shares. Virtu Fin reported 0% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Credit Suisse Ag invested 0.05% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). First Mercantile Tru, a Tennessee-based fund reported 2,714 shares. American Grp Inc invested in 0% or 11,257 shares. Wasatch invested 0.49% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Proshare Advsrs Limited Liability Corporation invested in 15,640 shares or 0.01% of the stock. 13,700 are held by Atika Capital Mgmt Limited Liability Company. Price T Rowe Assoc Inc Md invested in 78,364 shares or 0% of the stock. Next Fincl Grp holds 0% or 61 shares. Sei Invests Com reported 1,020 shares stake.

Ratings analysis reveals 50% of Koppers Holdings’s analysts are positive. Out of 2 Wall Street analysts rating Koppers Holdings, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. KOP was included in 2 notes of analysts from November 29, 2016. The stock of Koppers Holdings Inc. (NYSE:KOP) earned “Outperform” rating by Barrington Research on Wednesday, December 28. The rating was downgraded by Wunderlich on Tuesday, November 29 to “Hold”.

Harvey Partners Llc holds 2.52% of its portfolio in Koppers Holdings Inc. for 47,500 shares. Ironwood Investment Management Llc owns 70,121 shares or 2.27% of their US portfolio. Moreover, Southernsun Asset Management Llc has 1.18% invested in the company for 1.04 million shares. The Massachusetts-based Redwood Investments Llc has invested 0.88% in the stock. Fuller & Thaler Asset Management Inc., a California-based fund reported 1.34 million shares.